Hjem › Ulcerøs colitis › Kentucky
Ulcerøs colitis kliniske forsøg i Kentucky
13 studier for Ulcerøs colitis søger deltagere på steder i Kentucky.
Byer i Kentucky
Officiel studietekst (engelsk)
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Gastroenterology Health Partners /ID# 284144, Louisville
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Tri-State Gastroenterology Associates, Crestview Hills
RekruttererFase 4
Alder 18 til 80 · Alle køn · Opdateret 30. sep. 2026 · NCT06581328Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Xencor Investigative Site, Louisville
RekruttererFase 1/2Frivillige med god helbredstilstand velkomne
Alder 18 til 75 · Alle køn · Opdateret 29. sep. 2026 · NCT06619990A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 030, Louisville
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 29. sep. 2026 · NCT07012395A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- Tri-State Gastroenterology Assoc, Crestview Hills
RekruttererFase 3
Alder 12 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT07196748Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Gastroenterology Health Partners, Louisville
RekruttererFase 3
Alder 18 til 70 · Alle køn · Opdateret 24. sep. 2026 · NCT06937086Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of Kentucky/Markey Cancer Center, Lexington
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT03816345LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Gastroenterology Health Partners, Louisville
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 22. sep. 2026 · NCT07186101LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Gastroenterology Health Partners, Louisville
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 22. sep. 2026 · NCT07415044A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- University of Louisville, Louisville
RekruttererFase 4
Alder 18 til 65 · Alle køn · Opdateret 21. sep. 2026 · NCT06095128A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- Tri-State Gastroenterology Assoc, Crestview Hills
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. aug. 2026 · NCT07577856An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- University of Kentucky Hospital/UK Albert B. Chandler Hospital - Site Number: 8400058, Lexington
RekruttererFase 3
Alder 16 til 80 · Alle køn · Opdateret 20. aug. 2026 · NCT07184996Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
- University of Louisville, Louisville
Rekrutterer
Alder 18 til 85 · Alle køn · Opdateret 8. jan. 2026 · NCT05987852Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.